Posted Aug. 14, 2013 at 8:43 p.m.

Premium Lock Chimerix antiviral's phase II results 'encouraging' but company mum on details

Published: 2013-08-14 20:43:45
Updated: 2013-08-14 20:43:45

Chimerix drug pipeline as cited in IPO filing. Chimerix drug pipeline as cited in IPO filing.

Chimerix antiviral CMX001's phase II results were not statistically significant compared to a placebo. Executives explain why the results are encouraging....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2015 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders